Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A. Proia, Yumiko Wada|Investigational New Drugs|2012Cited by 79
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancerSuqin He, David A. Proia|Investigational New Drugs|2014Cited by 73
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, David A. Proia|International Journal of Oncology|2012Cited by 60
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C. Friedland, David A. Proia|Investigational New Drugs|2013Cited by 58
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancerDonald L. Smith, David A. Proia|Targeted Oncology|2014Cited by 37